PDS Biotechnology Corp. (PDSB)
1.165
+0.14
(+13.11%)
USD |
NASDAQ |
May 21, 16:00
1.165
0.00 (0.00%)
After-Hours: 16:25
PDS Biotechnology EPS Diluted (Quarterly) : -0.1324 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Altimmune, Inc. | -0.1813 |
| INmune Bio, Inc. | -0.2034 |
| Humacyte, Inc. | -0.089 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.349M |
| Total Expenses (Quarterly) | 7.349M |
| Enterprise Value | 51.69M |
| Earnings Yield | -57.56% |
| Normalized Earnings Yield | -57.56 |